Subscribe to our Newsletters !!
The safety and quality of produced medicines is ex
Automation of sample preparation has become the mo
A new COVID-19 variant, BA.3.2, informally called
Alembic Pharmaceutica
Can gene editing be used as a life-saving treatmen
Tofu used to be associated with Asian cuisine, but
Dear Readers, Welcome to a fresh and forward-look
Lupin has gotten endorsement for its Trientine Hydrochloride Capsules USP, 250 mg, from the United States Food and Drug Administration (USFDA), to showcase a conventional likeness Syprine Capsules, 250 mg, of Bausch Health US, LLC.
The item would be fabricated at Lupin’s Nagpur (Unit 1) office, India.
Trientine Hydrochloride Capsules USP, 250 mg, are demonstrated in the treatment of patients with Wilson’s ailment who are narrow minded of penicillamine.
Trientine Hydrochloride Capsules USP (RLD: Syprine) had a yearly deals of around USD 86 million in the U. S.
